Brainstorm Cell Therapeutics (BCLI) Files $200M Mixed Shelf
Get Alerts BCLI Hot Sheet
Join SI Premium – FREE
Brainstorm Cell Therapeutics (NASDAQ: BCLI) files $200,000,000 mixed shelf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood prices $2B convertible notes offering due 2029
- A.O. Smith executive chairman to retire, CEO to assume chairman role
- Gil Issachar steps down as CTO at Firefly Neuroscience
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share